Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2003 December;55(4) > Minerva Urologica e Nefrologica 2003 December;55(4):263-75

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Urologica e Nefrologica 2003 December;55(4):263-75

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: English

External beam radiotherapy as definitive treatment for prostate cancer

Sosa M., Sanguineti G.

Department of Radiation Oncology University of Texas Medical Branch Galveston, TX, USA


PDF


External beam radiotherapy (EBRT) planning and delivery has dramatically changed in the last 2 decades allowing dose escalation to the prostate while maintaining the same risk of complications.
EBRT plays a major role in the treatment of localized (T1-2) and locally advanced (T3-4) prostate cancer. In this review we will focus on some current issues associated with the “modern” use of EBRT such as what to expect from EBRT in terms of tumor control and side effects, what is the role of biopsy and surgery after EBRT, what is the role of androgen deprivation (AD), and how EBRT compares to brachytherapy.

top of page